August 14, 2018 Among the more than 1 million people in the U.S. living with HIV, 19 percent meet the criteria for an alcohol use disorder. The consequences can be severe, with heavy drinking associated with increased liver disease, greater engagement in risky sexual behavior, lower adherence to antiretroviral therapy and greater risk of death. […]Continue Reading ...
Credit: CC0 Public Domain Among the more than 1 million people in the U.S. living with HIV, 19 percent meet the criteria for an alcohol use disorder. The consequences can be severe, with heavy drinking associated with increased liver disease, greater engagement in risky sexual behavior, lower adherence to antiretroviral therapy and greater risk of […]Continue Reading ...
Thousands of experts and activists descend on Amsterdam Monday to bolster the battle against AIDS amid warnings that “dangerous complacency” may cause a resurgence of the epidemic that has already killed 35 million people. Rather than closing in on the goal of “ending” AIDS, new HIV infections have surged in parts of the world as […]Continue Reading ...
August 7, 2018 Extended-release naltrexone — an injection that decreases heavy drinking in the general population when taken in conjunction with counseling — appears to help HIV-positive individuals reduce their number of heavy drinking days too, say Yale researchers. This study was published online on Aug. 2 in AIDS and Behavior. “While we know that […]Continue Reading ...
HIV infecting a human cell. Credit: NIH Researchers have reported the results of the first randomised clinical trial to test a novel strategy involving waking up and then killing the ‘sleeping’ HIV that is hiding in the body using an experimental approach known as ‘kick and kill’. Led by Imperial College London, the University of […]Continue Reading ...
August 3, 2018 Many barriers prevent people from getting tested for HIV, including lack of knowledge, competing priorities during medical visits, and stigma associated with the test on the part of both the patient and provider. Not much is known, however, about what impact age and ethnicity have on HIV testing. Brandon Brown, an HIV […]Continue Reading ...
KENILWORTH, N.J.–(BUSINESS WIRE)–July 24, 2018 — Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced Week 96 results from the Phase 3 DRIVE-FORWARD clinical trial evaluating the efficacy and safety of doravirine (DOR), the company’s investigational non-nucleoside reverse transcriptase inhibitor (NNRTI), in combination with other antiretroviral agents, for the treatment […]Continue Reading ...
By Dr Ananya Mandal, MDJuly 26, 2018 HIV infections on the rise among teenage girls According to a new report from the United Nations children’s fund UNICEF, more and more adolescent girls are being infected with HIV. The report estimates around 30 teenagers being infected with HIV each hour. Of these 30 infections among those […]Continue Reading ...
Credit: CC0 Public Domain The International Antiviral Society-USA Panel has released updated recommendations for the treatment and prevention of HIV infection in adults, published in the Journal of the American Medical Association. Michael Saag, M.D., director of the University of Alabama at Birmingham’s Center for AIDS Research, served as the article’s lead author. The recommendations, […]Continue Reading ...
August 10, 2018 HIV-1 replicates in ninja-like ways. The virus slips through the membrane of vital white blood cells. Inside, HIV-1 copies its genes and scavenges parts to build a protective bubble for its copies. Scientists don’t understand many of the details of how HIV-1 can fool our immune system cells so effectively. The virus […]Continue Reading ...
August 7, 2018 Johns Hopkins scientists report they have identified two potential new drug targets for the treatment of HIV. The finding is from results of a small, preliminary study of 19 people infected with both HIV-;the virus that causes AIDS-;and the hepatitis C virus. The study revealed that two genes-;CMPK2 and BCLG, are selectively […]Continue Reading ...
Credit: The City University of New York HIV testing is a first step and key to stemming the rate of HIV infections around the world. In sub-Saharan African countries, HIV testing rates continue to be suboptimal, creating an urgent need to explore strategic and cost-effective approaches to increase the uptake of HIV testing, particularly among […]Continue Reading ...
August 1, 2018 In a recently published study in the journal Nature Microbiology, researchers at Los Alamos National Laboratory show that computer simulations can accurately predict the transmission of HIV across populations, which could aid in preventing the disease. The simulations were consistent with actual DNA data obtained from a global public HIV database, developed […]Continue Reading ...
July 31, 2018 The scientific group of Peter the Great St.Petersburg Polytechnic University headed by Professor Andrei Kozlov published the results of a study devoted to the search of solutions for creating the HIV vaccine. During two years, with the support of the Russian Science Foundation’s grant, researchers studied features of transmitted variants of HIV-1 […]Continue Reading ...
Inositol hexakisphosphate fits into the pore structures (pink) of the HIV capsid (teal), and makes the makes the capsid stronger, protecting the genetic material inside. Credit: UNSW Scientists from UNSW Sydney and the UK have discovered that the human immunodeficiency virus (HIV) hijacks a small molecule from the host cell to protect itself from being […]Continue Reading ...
- Scientists explore ways for drug therapies to reach deadly brain tumors
- Rethinking fundamental rule of stroke care: ‘Time is brain!’
- Scientists reveal role of ‘junk DNA’ in cancer dissemination
- Google’s DeepMind AI could soon be diagnosing eye conditions
- Scientists trick the brain to embody the prosthetic limb
- Researchers focus on uncoupling obesity from diabetes
- A class of proteins shown to be effective in reducing drug-seeking behaviors
- Gemphire Announces Termination of Phase 2a Clinical Trial of Gemcabene in Pediatric NAFLD
- Rheumatoid arthritis in pregnancy associated with low birth weight and premature birth
- Study may help increase effectiveness of antibiotics against drug-resistant bacteria
- Robotic walking frame aims to help maintain mobility of older adults
- Simple intervention during routine care reduces alcohol consumption in men with HIV
- Genetics Home Reference: gout
- Scientists ID genesis of disease, focus efforts on shape-shifting tau
- OncoThira and NDSU enter into license agreement to develop, market cancer compounds
- Scientists unravel the mystery behind ovarian cancer with high-grade serous carcinoma
- Common signs that indicate vision problems in children
- Removing the cancer label – overhaul in cancer classification proposed
- Prams may expose babies and toddlers to more air pollution finds study
- Duke researchers track missing T-cells in glioblastoma patients